Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mireia Morgades

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Medicina Clinica|May 6, 2011
[Salvage treatment with infliximab of steroid-resistant graft-versus-host disease in allogeneic transplanted patients]Cristina Motlló, Christelle Ferrà, Laia López, et al.
Medicina Clinica|May 9, 2008
[Similar prognosis for transplanted and non-transplanted patients with hematological malignancy admitted to the intensive care unit]Christelle Ferrà, Pilar Marcos, Mireia Morgades, et al.
Medicina Clinica|November 8, 2020
Outcomes of unrelated donor stem cell transplantation with or without anti-thymocyte globulin used as graft-versus-host disease prophylaxis in patients with acute leukaemia and myelodysplastic syndromeGeorgina Gener, Montserrat Batlle, Mireia Morgades, et al.
Medicina Clinica|March 18, 2008
[High-dose ifosfamide and etoposide regimen as salvage and mobilization therapy for patients with lymphoma]Susana Vives, Juan-Manuel Sancho, Jordi Juncà, et al.
Haematologica|January 2, 2008
Decrease in the frequency of meningeal involvement in AIDS-related systemic lymphoma in patients receiving HAARTJosé-Tomás Navarro, Ferran Vall-Llovera, José-Luis Mate, et al.
European Journal of Haematology|February 17, 2017
Impact of induction treatment before autologous stem cell transplantation on long-term outcome in patients with newly diagnosed multiple myelomaSusanna Gassiot, Cristina Motlló, Inuska Llombart, et al.
Medicina Clinica|September 8, 2015
[Comparative study on the usefulness of antibacterial prophylaxis with levofloxacin in patients submitted to hematopoietic stem cell transplantation]Jesús Fernandez Sojo, Montserrat Batlle Massana, Mireia Morgades, et al.
Medicina Clinica|February 2, 2017
Usefulness of bronchoalveolar lavage and flow cytometry in patients with hematological malignancies and respiratory failureChristelle Ferrà, Blanca Xicoy, Nerea Castillo, et al.
Leukemia & Lymphoma|October 9, 2010
Immunohistochemical expression profile and prognosis in patients with diffuse large B-cell lymphoma with or without human immunodeficiency virus infectionBlanca Xicoy, Josep-Maria Ribera, José-Luís Mate, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 1, 2019
Response to First Cycle Is the Major Predictor of Long-Term Response to Lenalidomide and Dexamethasone Therapy in Relapsed and Refractory Multiple Myeloma: Can We Spare Patients the Toxicity and Costs of Additional Agents?Susanna Gassiot, Yolanda González, Mireia Morgades, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Medicina Clinica|May 6, 2011
[Salvage treatment with infliximab of steroid-resistant graft-versus-host disease in allogeneic transplanted patients]Cristina Motlló, Christelle Ferrà, Laia López, et al.
Medicina Clinica|May 9, 2008
[Similar prognosis for transplanted and non-transplanted patients with hematological malignancy admitted to the intensive care unit]Christelle Ferrà, Pilar Marcos, Mireia Morgades, et al.
Medicina Clinica|November 8, 2020
Outcomes of unrelated donor stem cell transplantation with or without anti-thymocyte globulin used as graft-versus-host disease prophylaxis in patients with acute leukaemia and myelodysplastic syndromeGeorgina Gener, Montserrat Batlle, Mireia Morgades, et al.
Medicina Clinica|March 18, 2008
[High-dose ifosfamide and etoposide regimen as salvage and mobilization therapy for patients with lymphoma]Susana Vives, Juan-Manuel Sancho, Jordi Juncà, et al.
Haematologica|January 2, 2008
Decrease in the frequency of meningeal involvement in AIDS-related systemic lymphoma in patients receiving HAARTJosé-Tomás Navarro, Ferran Vall-Llovera, José-Luis Mate, et al.
European Journal of Haematology|February 17, 2017
Impact of induction treatment before autologous stem cell transplantation on long-term outcome in patients with newly diagnosed multiple myelomaSusanna Gassiot, Cristina Motlló, Inuska Llombart, et al.
Medicina Clinica|September 8, 2015
[Comparative study on the usefulness of antibacterial prophylaxis with levofloxacin in patients submitted to hematopoietic stem cell transplantation]Jesús Fernandez Sojo, Montserrat Batlle Massana, Mireia Morgades, et al.
Medicina Clinica|February 2, 2017
Usefulness of bronchoalveolar lavage and flow cytometry in patients with hematological malignancies and respiratory failureChristelle Ferrà, Blanca Xicoy, Nerea Castillo, et al.
Leukemia & Lymphoma|October 9, 2010
Immunohistochemical expression profile and prognosis in patients with diffuse large B-cell lymphoma with or without human immunodeficiency virus infectionBlanca Xicoy, Josep-Maria Ribera, José-Luís Mate, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 1, 2019
Response to First Cycle Is the Major Predictor of Long-Term Response to Lenalidomide and Dexamethasone Therapy in Relapsed and Refractory Multiple Myeloma: Can We Spare Patients the Toxicity and Costs of Additional Agents?Susanna Gassiot, Yolanda González, Mireia Morgades, et al.
Pageof 7